Active Ingredient History

  • Now
Tanezumab is a monoclonal antibody against nerve growth factor as a treatment for pain via a novel mechanisms different from conventional pain-killer drugs. Tanezumab was discovered and developed by Rinat Neuroscience and was acquired by Pfizer in 2006.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
anti-ngf ab | pf04383119 | pf 04383119 | pf-04383119 | pf4383119 | pf 4383119 | pf-4383119 | ri 624 | ri-624 | ri624 mab | rn624 | rn 624 | rn-624 | rn624 mab | tanezumab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue